Sub-Lingual Dexmedetomidine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sub-Lingual Dexmedetomidine, covering 2023-09-21 to 2023-09-21. Get the full timeline:
Most recent: Clinical Trial Update: Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia [Phase 1, Phase 2]